nach oben

Current Urology Reports

Erschienen in:

01.08.2016 | Benign Prostatic Hyperplasia (K McVary, Section Editor)

Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia

verfasst von: Joseph J. Pariser, Vignesh T. Packiam, Melanie A. Adamsky, Gregory T. Bales

Erschienen in: Current Urology Reports | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

The definitive treatment for symptomatic large volume (>80 mL) benign prostatic hyperplasia (BPH) is simple prostatectomy (SP). This can be performed by utilizing a retropubic, suprapubic, or a combined approach. The latter two approaches allow for the management of concomitant bladder diverticulum or stones through the same incision. Each approach affords unique technical strengths and weaknesses that must be considered in light of patient characteristics and concomitant pathology. SP allows for removal of the entire prostatic adenoma while obviating some of the neurovascular and continence issues that can arise from radical prostatectomy. Concerns with SP include its relatively high perioperative morbidity, notably bleeding. Therefore, there is increasing interest in less invasive options, including enucleation procedures and minimally invasive SP. This review presents an update regarding trends and outcomes of SP, as well as the effectiveness and popularity of alternative treatments.

1.••

Pariser JJ, Pearce SM, Patel SG, Bales GT. National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes. Urology. 2015;86:721–5. This manuscript represents the largest national database study regarding trends in the use of SP with a multivariate analysis of risk factors for complications.CrossRefPubMed

Jones P, Alzweri L, Rai BP, Somani BK, Bates C, Aboumarzouk OM. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol. 2016;14:50–8.CrossRefPubMed

Lee C, Kozlowski JM, Grayhack JT. Etiology of benign prostatic hyperplasia. Urol Clin N Am. 1995;22:237–46.

Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997;31:131–8.CrossRefPubMed

Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin N Am. 2009;36:443–59.CrossRef

McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12:S122–8.PubMed

Wright EJ, Fang J, Metter EJ, Partin AW, Landis P, Chan DW, et al. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging. J Urol. 2002;167:2484–7.CrossRefPubMed

Blankstein U, Van Asseldonk B, Elterman DS. BPH update: medical versus interventional management. Can J Urol. 2016;23:10–5.PubMed

Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57:123–31.CrossRefPubMed

10.

Roehrborn CG, Barkin J, Siami P, Tubaro A, Wilson TH, Morrill BB, et al. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int. 2011;107:946–54.CrossRefPubMed

11.

McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387–98.CrossRefPubMed

12.

McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185:1793–803.CrossRefPubMed

13.

Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJMCH. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46:547–54.CrossRefPubMed

14.

Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O’Leary MP, et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol. 1995;154:205–6.CrossRefPubMed

15.

Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol. 1999;36 Suppl 3:7–13.CrossRefPubMed

16.

Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120–4.CrossRefPubMed

17.

Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C. Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 2004;64:306–10.CrossRefPubMed

18.

Parsons JK, Rangarajan SS, Palazzi K, Chang D. A national, comparative analysis of perioperative outcomes of open and minimally invasive simple prostatectomy. J Endourol. 2015;29:919–24.CrossRefPubMed

19.

Chughtai BI, Simma-Chiang V, Lee R, Isaacs A, Te AE, Kaplan SA, et al. Trends and utilization of laser prostatectomy in ambulatory surgical procedures for the treatment of benign prostatic hyperplasia in New York State (2000–2011). J Endourol. 2015;29:700–6.CrossRefPubMed

20.••

Lowrance WT, Southwick A, Maschino AC, Sandhu JS. Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. J Urol. 2013;189:1811–6. This study reports on the urologist-level practice patterns in the treatment of BPH. Notably, endoscopic laser procedures are gaining in popularity, especially with younger physicians.CrossRefPubMed

21.

Serretta V, Morgia G, Fondacaro L, Curto G. Lo bianco A, Pirritano D, et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002;60:623–7.CrossRefPubMed

22.

Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007;177:1419–22.CrossRefPubMed

23.

Abrams PH, Shah PJ, Bryning K, Gaches CG, Ashken MH, Green NA. Blood loss during transurethral resection of the prostate. Anaesthesia. 1982;37:71–3.CrossRefPubMed

24.

Montesi L, Quaresima L, Tiroli M, Lacetera V, Cantoro U, Sbrollini G, et al. Improvement of lower urinary tract symptoms and sexual activity after open simple prostatectomy: prospective analysis of 50 cases. Arch Ital Urol Androl. 2014;86:353–5.CrossRefPubMed

25.•

Chen S, Zhu L, Cai J, Zheng Z, Ge R, Wu M, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol. 2014;66:284–91. This was a randomized trial of plasmakinetic enucleation and open prostatectomy. The enucleation procedure demonstrated similar long-term voiding outcomes with improved perioperative morbidity.CrossRefPubMed

26.

Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–6.CrossRefPubMed

27.

Elshal AM, El-Nahas AR, Barakat TS, Elsaadany MM, El-Hefnawy AS. Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: perioperative outcomes of a contemporary series. Arab J Urol. 2013;11:362–8.CrossRefPubMedPubMedCentral

28.••

Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, et al. Perioperative Outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis. Eur Urol. 2015;68:86–94. This is a very large multi-institutional study regarding the perioperative outcomes of minimally invasive simple prostatectomy. They demonstrate good outcomes of the procedure across multiple centers.CrossRefPubMed

29.

Humphreys M, Miller N, Handa S, Terry C, Munch L, Lingeman J. Holmium laser enucleation of the prostate—outcomes independent of prostate size? J Urol. 2008;180:2431–5.CrossRefPubMed

30.

Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases—a medium term, prospective, randomized comparison. BJU Int. 2013;111:793–803.CrossRefPubMed

31.

Sivarajan G, Borofsky MS, Shah O, Lingeman JE, Lepor H. The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy. Rev Urol. 2015;17:140–9.PubMedPubMedCentral

32.

Salonia A, Suardi N, Naspro R, Mazzoccoli B, Zanni G, Gallina A, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis. Urology. 2006;68:302–6.CrossRefPubMed

33.•

Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol. 2013;63:859–67. This is a very large study (n = 1080) regarding thulium laser vapoenucleation of the prostate and perioperative outcomes with improvements in complication rates seen throughout their experience.CrossRefPubMed

34.

El-Hakim A, Elhilali MM. Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int. 2002;90:863–9.CrossRefPubMed

35.

Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB. Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol. 2007;177:1468–74.CrossRefPubMed

36.

Mariano MB, Graziottin TM, Tefilli MV. Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia. J Urol. 2002;167:2528–9.CrossRefPubMed

37.•

Pavan N, Zargar H, Sanchez-Salas R, Castillo O, Celia A, Gallo G, et al. Robot-assisted versus standard laparoscopy for simple prostatectomy: multicenter comparative outcomes. Urology. 2016 (in press). This is a comparative analysis of robotic and laparoscopic simple prostatectomy across multiple centers. Both procedures were safe approaches to treat BPH in very large glands.

38.

Baumert H, Ballaro A, Dugardin F, Kaisary AV. Laparoscopic versus open simple prostatectomy: a comparative study. J Urol. 2006;175:1691–4.CrossRefPubMed

39.

McCullough TC, Heldwein FL, Soon SJ, Galiano M, Barret E, Cathelineau X, et al. Laparoscopic versus open simple prostatectomy: an evaluation of morbidity. J Endourol. 2009;23:129–33.CrossRefPubMed

Titel: Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia
verfasst von: Joseph J. Pariser
Vignesh T. Packiam
Melanie A. Adamsky
Gregory T. Bales
Publikationsdatum: 01.08.2016
Verlag: Springer US
Erschienen in: Current Urology Reports / Ausgabe 8/2016
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-016-0610-6

Neu im Fachgebiet Urologie

24.04.2024 | DGIM 2024 | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia

Abstract

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

How to Avoid and Deal with Pelvic Mesh Litigation

Hormone-Based Treatments in Subfertile Males

Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes

3-D Imaging and Simulation for Nephron Sparing Surgical Training

Three-Dimensional Imaging of Urethral Stricture Disease and Urethral Pathology for Operative Planning

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie